首页> 外国专利> -Siglec-8 -Siglec-F -IL-33 Composition for allergic diseases comprising anti-Siglec-8 antibody or anti-Siglec-F antibody and anti-IL-22 antibody

-Siglec-8 -Siglec-F -IL-33 Composition for allergic diseases comprising anti-Siglec-8 antibody or anti-Siglec-F antibody and anti-IL-22 antibody

机译:-Siglec-8 -Siglec-F -IL-33用于变应性疾病的组合物,其包含抗-Siglec-8抗体或抗-Siglec-F抗体和抗-IL-22抗体

摘要

The present invention relates to a pharmaceutical composition for the prophylaxis or treatment of an allergic disease comprising an anti-Siglec-8 antibody and / or an anti-Siglec-F antibody, and an anti-IL-33 antibody. The invention also relates to a food or cosmetic composition for the prevention or amelioration of an allergic disease comprising an anti-Siglec-8 antibody and / or an anti-Siglec-F antibody, and an anti-IL-33 antibody. The combined administration of the anti-Siglec-8 antibody and / or the anti-Siglec-F antibody and the anti-IL-33 antibody of the present invention is superior to the administration of the anti-Siglec-F antibody or the anti- Significant alleviation of allergic symptoms in sex-diseased animal models allows effective prevention and treatment of allergic diseases.
机译:本发明涉及用于预防或治疗变应性疾病的药物组合物,其包含抗Siglec-8抗体和/或抗Siglec-F抗体和抗IL-33抗体。本发明还涉及用于预防或改善变应性疾病的食品或化妆品组合物,其包含抗-Siglec-8抗体和/或抗-Siglec-F抗体和抗IL-33抗体。本发明的抗-Siglec-8抗体和/或抗-Siglec-F抗体和抗IL-33抗体的联合施用优于抗-Siglec-F抗体或抗-Siglec-F抗体的联合施用。性病动物模型中过敏症状的显着缓解可以有效预防和治疗过敏性疾病。

著录项

  • 公开/公告号KR101567758B1

    专利类型

  • 公开/公告日2015-11-11

    原文格式PDF

  • 申请/专利权人 인하대학교 산학협력단;

    申请/专利号KR20130124045

  • 发明设计人 김영효;장태영;

    申请日2013-10-17

  • 分类号A61K39/395;A61P11;A61P11/06;

  • 国家 KR

  • 入库时间 2022-08-21 14:15:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号